Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | MMP12 | P39900 | 1/20 | 0.31 |
| ▸ | MMP13 | P45452 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20205646 | 0.91 | ALOX5 (0.36) | PRKDCPGRALOX5 | |
| SCHEMBL20205631 | 0.89 | ALOX5 (0.36) | PRKDCPGRALOX5KDM4EMEN1 | |
| SCHEMBL20205647 | 0.89 | ALOX5 (0.38) | PRKDCPGRALOX5KDM4EMEN1 | |
| SCHEMBL21533729 | 0.88 | ALOX5 (0.33) | ALOX5 | |
| SCHEMBL20205291 | 0.87 | ALOX5 (0.34) | ALOX5 | |
| SCHEMBL21533771 | 0.87 | PGR (0.33) | PGRKDM4EMEN1ALDH1A1MAPT | |
| SCHEMBL20205629 | 0.87 | MMP12 (0.37) | PRKDCPGRALOX5KDM4EMEN1 | |
| SCHEMBL23351580 | 0.87 | ALOX5 (0.36) | PRKDCPGRALOX5KDM4EMEN1 | |
| SCHEMBL21533728 | 0.86 | ALOX5 (0.34) | PGRALOX5KDM4EMEN1MAPT | |
| SCHEMBL20205371 | 0.86 | ALOX5 (0.37) | PRKDCPGRALOX5KDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190330152-A1 | FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190330152-A1 | FUSED RING COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION, AND ORGANIC ELECTRONIC COMPONENT | EED, OCIAD2, OCIAD1 | PRKDC 2617/4885PGR 608/4885ALOX5 539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.